BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38437062)

  • 21. Interleukin-8 Induces Expression of FOXC1 to Promote Transactivation of CXCR1 and CCL2 in Hepatocellular Carcinoma Cell Lines and Formation of Metastases in Mice.
    Huang W; Chen Z; Zhang L; Tian D; Wang D; Fan D; Wu K; Xia L
    Gastroenterology; 2015 Oct; 149(4):1053-67.e14. PubMed ID: 26065367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated TEFM expression promotes growth and metastasis through activation of ROS/ERK signaling in hepatocellular carcinoma.
    Wan L; Wang Y; Zhang Z; Wang J; Niu M; Wu Y; Yang Y; Dang Y; Hui S; Ni M; Wan B; Bao D
    Cell Death Dis; 2021 Mar; 12(4):325. PubMed ID: 33771980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual roles of glutathione S-transferase mu 1 in the development and metastasis of hepatocellular carcinoma.
    Lu Y; Zhou J; Zhang J; Wang Z; Yu Y; Miao M; Yao Q
    Biomed Pharmacother; 2019 Dec; 120():109532. PubMed ID: 31605953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
    Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PKCδ mediates mitochondrial ROS generation and oxidation of HSP60 to relieve RKIP inhibition on MAPK pathway for HCC progression.
    Mandal JP; Shiue CN; Chen YC; Lee MC; Yang HH; Chang HH; Hu CT; Liao PC; Hui LC; You RI; Wu WS
    Free Radic Biol Med; 2021 Feb; 163():69-87. PubMed ID: 33307168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pentoxifylline induces apoptosis of HepG2 cells by reducing reactive oxygen species production and activating the MAPK signaling.
    Wang Y; Dong L; Li J; Luo M; Shang B
    Life Sci; 2017 Aug; 183():60-68. PubMed ID: 28583366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.
    Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L
    J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRPL21 promotes HCC proliferation through TP53 mutation-induced apoptotic resistance.
    Ma T; Huang YB; Chen J; Zhang L; Liu YH; Lu CH
    Tissue Cell; 2024 Feb; 86():102298. PubMed ID: 38181584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eukaryotic translation initiation factor 5A2 regulates the migration and invasion of hepatocellular carcinoma cells via pathways involving reactive oxygen species.
    Liu RR; Lv YS; Tang YX; Wang YF; Chen XL; Zheng XX; Xie SZ; Cai Y; Yu J; Zhang XN
    Oncotarget; 2016 Apr; 7(17):24348-60. PubMed ID: 27028999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel benzimidazole derivative, MBIC inhibits tumor growth and promotes apoptosis via activation of ROS-dependent JNK signaling pathway in hepatocellular carcinoma.
    Dai X; Wang L; Deivasigamni A; Looi CY; Karthikeyan C; Trivedi P; Chinnathambi A; Alharbi SA; Arfuso F; Dharmarajan A; Goh BC; Hui KM; Kumar AP; Mustafa MR; Sethi G
    Oncotarget; 2017 Feb; 8(8):12831-12842. PubMed ID: 28086233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration.
    Xu Q; Liao Z; Gong Z; Liu X; Yang Y; Wang Z; Yang W; Hou L; Yang J; Song J; Liu W; Wang B; Hua J; Pu M; Li N
    Cell Mol Biol Lett; 2022 Oct; 27(1):93. PubMed ID: 36273122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PYCR1 interference inhibits cell growth and survival via c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathway in hepatocellular cancer.
    Zhuang J; Song Y; Ye Y; He S; Ma X; Zhang M; Ni J; Wang J; Xia W
    J Transl Med; 2019 Oct; 17(1):343. PubMed ID: 31619254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NUPR1 contributes to radiation resistance by maintaining ROS homeostasis via AhR/CYP signal axis in hepatocellular carcinoma.
    Zhan Y; Zhang Z; Liu Y; Fang Y; Xie Y; Zheng Y; Li G; Liang L; Ding Y
    BMC Med; 2022 Oct; 20(1):365. PubMed ID: 36258210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NQO1 Mediates Lenvatinib Resistance by Regulating ROS-induced Apoptosis in Hepatocellular Carcinoma.
    Xue W; Wang T; Tian WJ; Pang SQ; Zhang HF; Jia WD
    Curr Med Sci; 2024 Feb; 44(1):168-179. PubMed ID: 38217831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
    Tian F; Cai D
    Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of EGFL8 regulates migration, invasion and apoptosis of hepatocellular carcinoma through activating Notch signaling pathway.
    Wu F; Zhang FY; Tan GQ; Chen WJ; Huang B; Yan L; Zhang HL; Chen S; Jiao Y; Wang BL
    BMC Cancer; 2021 Jun; 21(1):704. PubMed ID: 34130659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. β-Thujaplicin induces autophagic cell death, apoptosis, and cell cycle arrest through ROS-mediated Akt and p38/ERK MAPK signaling in human hepatocellular carcinoma.
    Zhang G; He J; Ye X; Zhu J; Hu X; Shen M; Ma Y; Mao Z; Song H; Chen F
    Cell Death Dis; 2019 Mar; 10(4):255. PubMed ID: 30874538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of cancer susceptibility candidate 2 inhibited progression of hepatocellular carcinoma cells.
    Gao X; Du H; Zhang R; Li C; Wang H; Xuan Q; Liu D
    J Cell Physiol; 2019 Jun; 234(6):9008-9018. PubMed ID: 30362539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tripartite motif-containing 3 (TRIM3) inhibits tumor growth and metastasis of liver cancer.
    Huang XQ; Zhang XF; Xia JH; Chao J; Pan QZ; Zhao JJ; Zhou ZQ; Chen CL; Tang Y; Weng DS; Zhang JH; Xia JC
    Chin J Cancer; 2017 Sep; 36(1):77. PubMed ID: 28950898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transmembrane protein 106C promotes the development of hepatocellular carcinoma.
    Luo X; Han G; Lu R; Guan S; Wang Y; Ju L; Chen L; Shao J; Bian Z
    J Cell Biochem; 2020 Nov; 121(11):4484-4495. PubMed ID: 32037603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.